NASDAQ:VIVE Viveve Medical (VIVE) Stock Price, News & Analysis $0.0002 0.00 (0.00%) As of 10/23/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitors About Viveve Medical Stock (NASDAQ:VIVE) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Viveve Medical alerts:Sign Up Key Stats Today's Range$0.0002▼$0.000250-Day Range N/A52-Week Range$0.0001▼$0.0010VolumeN/AAverage Volume2,486 shsMarket Capitalization$434.00P/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Viveve Medical, Inc. was a women’s health company focused on developing and commercializing noninvasive treatments for vaginal health. Its principal product was the Viveve System, a medical device that used cryogen-cooled monopolar radiofrequency energy to heat and remodel tissue. The company promoted the system primarily for the treatment of vaginal laxity and related intimate-health concerns. The Viveve System was designed for use by healthcare professionals in office-based procedures and incorporated a disposable treatment tip. Viveve Medical sought regulatory clearances and commercial adoption in the United States and international markets, with distribution and clinical use reported in multiple countries. The company operated under the name Viveve, Inc. before adopting the Viveve Medical name. Publicly available information about its later operations, leadership, and current commercial activities is limited, and the company’s status and product availability may have changed since its period of public trading under the symbol VIVE.AI Generated. May Contain Errors. Read More Receive VIVE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Viveve Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VIVE Stock News HeadlinesViveve Medical Inc.August 22, 2026 | marketwatch.comViveve Medical Inc (VIVE)July 24, 2024 | investing.comTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and payment networks that bypass the dollar entirely. Since the Federal Reserve opened in 1913, the dollar has lost most of its purchasing power. Porter Stansberry argues a new monetary order is forming around AI infrastructure, chips and energy, pointing to stocks like Vertiv, GE Vernova and Arista Networks that have surged hundreds of percent in recent years. | Porter & Company (Ad)Incontinence Devices Pipeline Research Report 2024: Stages of Development, Segments, Region and Countries, Regulatory Path and Key CompaniesJuly 19, 2024 | finance.yahoo.comVaginal Rejuvenation Is Big BusinessJuly 19, 2024 | ca.style.yahoo.comVIVE Viveve Medical, Inc.July 29, 2023 | seekingalpha.comInMode Expands Women's Health and Wellness Market Footprint through Acquisition of Viveve PatentsJuly 25, 2023 | finance.yahoo.comVIVE - Viveve Medical, Inc.June 14, 2023 | uk.finance.yahoo.comSee More Headlines VIVE Stock Analysis - Frequently Asked Questions How have VIVE shares performed this year? Viveve Medical's stock was trading at $0.0001 at the start of the year. Since then, VIVE shares have increased by 100.0% and is now trading at $0.0002. How were Viveve Medical's earnings last quarter? Viveve Medical, Inc. (NASDAQ:VIVE) issued its quarterly earnings data on Thursday, November, 11th. The company reported ($0.67) earnings per share for the quarter, missing the consensus estimate of ($0.58) by $0.09. The company earned $1.62 million during the quarter. When did Viveve Medical IPO? Viveve Medical (VIVE) raised $13 million in an initial public offering (IPO) on Tuesday, June 14th 2016. The company issued 1,600,000 shares at $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group served as the underwriters for the IPO and Maxim Group was co-manager. How do I buy shares of Viveve Medical? Shares of VIVE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Viveve Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Nokia (NOK), Inovio Pharmaceuticals (INO), Plug Power (PLUG), Alibaba Group (BABA), NIO (NIO) and Evofem Biosciences (EVFM). Company Calendar Last Earnings11/11/2021Today10/25/2026Next Earnings (Estimated)11/13/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:VIVE Previous SymbolOTCMKTS:PLCSD CIK879682 Webwww.viveve.com Phone(720) 696-8100Fax720-696-8199Employees47Year Founded2005Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$6.83 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares2,170,000Free FloatN/AMarket Cap$434.00 OptionableNot Optionable Beta-0.16 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:VIVE) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredForget the AI predictions. Look at the incomeAI predictions are everywhere, but Tim Plaehn is focused on something concrete: income. He's found a small ...Investors Alley | SponsoredFinally… options made simpleIan Cooper once believed successful options trading meant endless chart-watching, complex strategies, and big ...TradeWins | SponsoredElon says the ‘S’ wordElon Musk and Sam Altman have sued each other and feuded for years. Yet within days of one another, both men d...Paradigm Press | SponsoredThe chip inside every TeslaEvery Tesla built since 2012 pays this small, overlooked supplier a fee for its technology. So does every Star...Behind the Markets | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredAsk a 20 Year Trading Pro Your Stock Questions Live for 5Ross Givens, a market analyst with over 20 years on Wall Street, goes live every Monday at 9 AM ET to break do...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viveve Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viveve Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
